Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo

GAO Reports by subject "Drug testing"

Full-text search of 52,071 reports from the Government Accountability Office
From To
Reset

Search Results:

Date Report No. Title
Date Nov. 9, 2009 Report No. GAO-10-68 Title

Drug Safety: FDA Has Begun Efforts to Enhance Postmarket Safety, but Additional Actions Are Needed

United States Government Accountability Office GAO November 2009 Report to the Ranking Member, Committee on Finance, U.S. Senate DRUG SAFETY FDA Has Begun Efforts to Enhance Postmarket Safety, but Additional Actions Are Needed GAO-10-68 November 2009 DRUG SAFETY Highlights Highlights of GAO-10-68, a report to the Ranking Member, Committee on Finance, U.S. Senate Accountability Integrity Reliabilit...
Date June 30, 2008 Report No. GAO-08-829R Title

Transportation: Examples of Job Hopping by Commercial Drivers After Failing Drug Tests

United States Government Accountability Office Washington, DC 20548 June 30, 2008 The Honorable James L. Oberstar Chairman Committee on Transportation and Infrastructure House of Representatives The Honorable Peter A. DeFazio Chairman Subcommittee on Highways and Transit Committee on Transportation and Infrastructure House of Representative Subject: Examples of Job Hopping by Commercial Drivers af...
Date May 15, 2008 Report No. GAO-08-600 Title

Motor Carrier Safety: Improvements to Drug Testing Programs Could Better Identify Illegal Drug Users and Keep Them off the Road

United States Government Accountability Office GAO May 2008 Report to Congressional Requesters MOTOR CARRIER SAFETY Improvements to Drug Testing Programs Could Better Identify Illegal Drug Users and Keep Them off the Road GAO-08-600 May 2008 MOTOR CARRIER SAFETY Highlights Highlights of GAO-08-600, a report to congressional requesters Accountability Integrity Reliability Improvements to Drug Testi...
Date May 22, 2007 Report No. GAO-07-898T Title

Pediatric Drug Research: The Study and Labeling of Drugs for Pediatric Use under the Best Pharmaceuticals for Children Act

United States Government Accountability Office GAO For Release on Delivery Expected at 10:00 a.m. EDT Tuesday, May 22, 2007 Testimony Before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives PEDIATRIC DRUG RESEARCH The Study and Labeling of Drugs for Pediatric Use under the Best Pharmaceuticals for Children Act Statement of Marcia Crosse Director, Health Care G...
Date March 22, 2007 Report No. GAO-07-557 Title

Pediatric Drug Research: Studies Conducted under Best Pharmaceuticals for Children Act

United States Government Accountability Office GAO March 2007 Report to Congressional Committees PEDIATRIC DRUG RESEARCH Studies Conducted under Best Pharmaceuticals for Children Act GAO-07-557 March 2007 PEDIATRIC DRUG RESEARCH Highlights Highlights of GAO-07-557, a report to congressional committees Accountability Integrity Reliability Studies Conducted under Best Pharmaceuticals for Children Ac...
Date Nov. 17, 2006 Report No. GAO-07-49 Title

New Drug Development: Science, Business, Regulatory, and Intellectual Property Issues Cited as Hampering Drug Development Efforts

United States Government Accountability Office GAO November 2006 Report to Congressional Requesters NEW DRUG DEVELOPMENT Science, Business, Regulatory, and Intellectual Property Issues Cited as Hampering Drug Development Efforts GAO-07-49 November 2006 NEW DRUG DEVELOPMENT Highlights Highlights of GAO-07-49, a report to congressional requesters Accountability Integrity Reliability Science, Busines...
Date May 17, 2005 Report No. GAO-05-653T Title

Drug Tests: Products to Defraud Drug Use Screening Tests Are Widely Available

United States Government Accountability Office GAO For Release on Delivery Expected at 9:30 a.m. EDT Tuesday, May 17, 2005 Testimony Before the Chairman, Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives DRUG TESTS Products to Defraud Drug Use Screening Tests Are Widely Available Statement of Robert J. Cramer, Managing Director Office of Speci...
Date Aug. 17, 2001 Report No. GAO-01-1051R Title

Justice and Law Enforcement: Criminal Justice Statistics for Washington, D.C., and Other Major Cities

United States General Accounting Office Washington, DC 20548 August 17, 2001 The Honorable Eleanor Holmes Norton Ranking Minority Member Subcommittee on the District of Columbia Committee on Government Reform House of Representatives Subject: Criminal Justice Statistics for Washington, D.C., and Other Major Cities Dear Ms. Norton: On July 20, 2001, we testified at an oversight hearing—which focu...
Date July 6, 2001 Report No. GAO-01-754 Title

Women's Health: Women Sufficiently Represented in New Drug Testing, but FDA Oversight Needs Improvement

United States General Accounting Office GAO July 2001 Report to Congressional Requesters WOMEN’S HEALTH Women Sufficiently Represented in New Drug Testing, but FDA Oversight Needs Improvement GAO-01-754 Contents Letter Results in Brief Background FDA’s Regulation Not As Specific As Earlier Guidance NDA and IND Submissions Often Fail to Present Required Information NDAs Include Appropriate Numb...
Date June 30, 2000 Report No. HEHS-00-135R Title

Medicare: Contractors Screen Employees but Extent of Screening Varies

United States General Accounting Office Washington, DC 20548 Health, Education, and Human Services Division B-285112 June 30, 2000 The Honorable John L. Mica Chairman, Subcommittee on Criminal Justice, Drug Policy, and Human Resources Committee on Government Reform House of Representatives Subject: Medicare: Contractors Screen Employees but Extent of Screening Varies Dear Mr. Chairman: In fiscal y...
Date July 31, 1997 Report No. GGD-97-106 Title

Drug Courts: Overview of Growth, Characteristics, and Results

United States General Accounting Office GAO July 1997 Report to the Committee on the Judiciary, U.S. Senate, and the Committee on the Judiciary, House of Representatives DRUG COURTS Overview of Growth, Characteristics, and Results GAO/GGD-97-106 GAO United States General Accounting Office Washington, D.C. 20548 General Government Division B-275268 July 31, 1997 The Honorable Orrin G. Hatch Chairma...
Date Feb. 11, 1993 Report No. GGD-93-61 Title

Drug Control: Treatment Alternatives Program for Drug Offenders Needs Stronger Emphasis

i I . -..-“-l_l... .--_I _.I_.... _1.-1---. _~.- ..-.---__. ^._..l,ll_* .-., I DRUG CONTROL Treatment Alternatives Program for Drug Offenders Needs Stronger Emphasis 148542 GAO United States General Accounting OfTIce Washington, D.C. 20848 General Government Division B-252082 February 11,1993 The Honorable Charles B. Range1 Chairman, Select Committee on Narcotics Abuse and Control House of Repre...
Date Nov. 23, 1992 Report No. GGD-93-13 Title

Employee Drug Testing: Opportunities Exist to Lower Drug-Testing Program Costs

NOWIII~WI l!W EMPLOYEE DRUG TESTING Opportunities Exist to Lower Drug-Testing Program Costs 148204 . RESTRICTED--Not to be released outside the General Accounting Office ui2less specifically approved by the Office of Congressional Relations:> s%629 RELEASED - .^ ._ _ ._., .._. . ._. ..-. ...- ...__ I *I- -_ . . . I . ...” I” . . .._ ..- ..__ _..... _.._ -.“.-_. “_ __“.“l II__ ._.------...
Date Oct. 29, 1992 Report No. HRD-93-17 Title

Women's Health: FDA Needs To Ensure More Study of Gender Differences in Prescription Drugs Testing

IJnited States General Accounting Office Report to Congressional Requesters Octobt?r 1992 WOMEN’ HEALTH S FDA Needs to Ensure More Study of Gender Differences~ in Prescription Drug Testing, II II 147861 GAO/HRD-93-1’ 7 . United States General Accounting Office Washington, D.C. 20548 Human Resources Division B-243898 October 29,1992 The Honorable Henry A. Waxman Chairman, Subcommittee on Health...
Date June 10, 1992 Report No. GGD-92-99 Title

Employee Drug Testing: Estimated Cost to Test All Executive Branch Employees and New Hires

IJtrit,ctrf States Gent!ral Accounting Olfiw
Date May 6, 1991 Report No. GGD-91-70 Title

Employee Drug Testing: Status of Federal Agencies' Programs

EMPLOYEE DRUG Status of Federal Agencies’ Programs GAO General Accounting Office Washington, D.C. 20648 National Security and International Affairs Division united states B-242712 May 6,199l The Honorable John Glenn Chairman, Committee on Governmental Affairs United States Senate Dear Mr. Chairman: This report, prepared in response to your request, discusses the status of federal agencies’ dru...
Date Feb. 19, 1991 Report No. T-GGD-91-6 Title

Employee Drug Testing: A Single Agency Is Needed To Manage Federal Employee Drug Testing

. ’ .’ . United States General Accounting Office / 4 31 7 q GAO For Release on Delivery 2:00 P.M. EST Tuesday February 19, 1991 Testimony EMPLOYEE DRUG TESTING A Single Manage Agency Federal Is Needed To Drug Testing Employee Statement of Bernard L. Ungar, Director Federal Human Resource Management General Government Division Before the Subcommittee on Treasury, and General Government Committe...
Date Jan. 18, 1991 Report No. GGD-91-25 Title

Employee Drug Testing: A Single Agency Is Needed to Manage Federal Employee Drug Testing

GAO -~-~.JiIllllary 1!)!)1 --- EMPLOYEE TESTING DRLJG A Single Agency Is Needed to Manage Federal Employee Drug Testing General Government Division B-240487 January 18,199l The Honorable Dennis DeConcini Chairman, Subcommittee on Treasury, Postal Service, and General Government Committee on Appropriations United States Senate The Honorable Barbara Mikulski United States Senate This report, prepare...
Date April 6, 1990 Report No. GGD-90-56FS Title

Drug Testing: Action by Certain Agencies When Employees Test Positive for Illegal Drugs

-7 United Sta\es General Accounting Office Gil0 April 1990 Fact Sheet for the Chairman, Subcommittee on Treasury, Postal Service, and General Government, Committee on Appropriations, US. Senate DRUG TESTING Action by Certain Agencies When Employees Test Positive for Illegal Drugs --, RlllHlllR RR 141330 ?a -~ GAO/GGD-90-66FS United States General Accounting Offke Washington, D.C. 20548 General Gov...
Date Nov. 27, 1989 Report No. RCED-90-31 Title

Drug Testing: Management Problems and Legal Challenges Facing DOT's Industry Programs

I United States General Accounting Office - GAO November 1989 on Investigations and Oversight, Committee on Public Works and Transportation, House of Representatives Report to the Chairman, Subcommittee - DRUG TESTING Management Problems and Legal Challenges Facing DOT’s Industry Programs Resources, Community, Economic Development and Division B-234505 November 27, 1989 The Honorable Glenn M. An...
Date Sept. 29, 1989 Report No. GGD-89-80 Title

Employee Drug Testing: DOT's Laboratory Quality Assurance Program Not Fully Implemented

RESTRICTED-- GAO United States General Accounting Office Washington, D.C. 20548 General Government Division B-235059 September 29,1989 The Honorable Dennis DeConcini Chairman, Subcommittee on Treasury, Postal Service, and General Government Committee on Appropriations United States Senate Dear Mr. Chairman: On August 2,1989, we briefed your representative as part of our ongoing review of agency dr...
Date May 30, 1989 Report No. GGD-89-75 Title

Employee Drug Testing: Agency Costs May Vary From Earlier Estimates

Not to be released outside RESTRICTED-General Accounting Office unless specifically approved by the Office of Congressional Relations. nrr morn the United States General Accounting Office Washington, D.C. 20548 General Government Division B-223280 May 30,1989 The Honorable Gerry Sikorski Chairman, Subcommittee on Civil Service Committee on Post Office and Civil Service House of Representatives The...
Date March 1, 1989 Report No. GGD-89-51 Title

Drug Testing: Federal Agency Plans for Testing Employees

, : .’ ^ GAO United States General Accounting Office Washington, D.C. 20648 General Government Division B-223280 March I,1989 The Honorable Dennis DeConcini Chairman, Subcommittee on Treasury, Postal Service, and General Government Committee on Appropriations United States Senate Dear Mr. Chairman: Senate Report loo-387 on the fiscal year 1989 Treasury, Postal Service, and General Government App...
Date Sept. 2, 1988 Report No. GGD-88-127FS Title

Employee Drug Testing: Regulation of Drug Testing Laboratories

United States General Accounting Office GAO September 1988 Fact Sheet for the Honorable Charles E. Schumer, House of Representatives EMPLOYEE DRUG TESTING Regulation of Drug Testing Laboratories !W3TRICTED--Not to be released outside the General Accounting Offke except on the basis of the specific approval by the Office of CongressionalRelations. GAO United States General Accounting Offke Washingt...
Date June 16, 1988 Report No. T-GGD-88-40 Title

Employment: Federal Employee Drug Testing

United States General Accounting OfBee / GAO Testimony For Release on Delivery Expected at 9:30 a.m. EDT Thursday June 16, 1988 FEDERAL EMPLOYEE DRUG TESTING Statement of Associate L. Nye Stevens, General Government Division Before the Subcommittee Director on Human Resources and on Civil Service Subcommittee Committee on Post Office and Civil United States House of Representatives Service 136078 ...
Date April 21, 1988 Report No. T-GGD-88-14 Title

Employment: Employee Drug Testing

UnitedStatesGeneralAccountingOffke Testimony For Release on Delivery Expected at 1O:OO a.m. EDT Thursday April 21, 1988 Employee Drug Testing Statement of Associate L. Fye Stevens, General Government Division Before the Subcommittee on Employment Committee on Education and Bouse of Representatives Director Opportunities Labor @b\qLtip GAO\T-GGD-88-14 I i-35 (c3C EMPLOYEE DRUG TESTING SUMMARY OF ST...
Date March 2, 1988 Report No. GGD-88-32 Title

Employee Drug Testing: Information on Private Sector Programs

- Charles Schumer, House of, Representatives . March1988 EMPLOYEEDRUG TESTING+: InformationonPrivak sector Programs RESTRICTED-Not to be re!easedoutside the Qneraf Accounting Of&e except on the basis of the specific approval by the Oflice of CongressionalRelations. 3AO/GGD-88-32 suc\L)38 GAO United States General Accounting Office Washington, D.C. 20548 General Government Division B-223280 March 2...
Date May 20, 1987 Report No. T-GGD-87-18 Title

Employment: Federal Employee Drug Testing

Unbd Stat& Gws~ral Accounting Of!fice 1% Testimony For Release on Delivery Expected at 9:30 a.m. EDT Wednesday May 20, 1987 FEDERAL EMPLOYEEDRUG TESTING . Statement of L. Nye Stevens, Associate Director General Government Division Before the Subcommittee on Human Resources Committee on Post Office and Civil Service United States House of Representatives 133001 03Y4~0 bAO/T-GGD-87-18 Mr. Chairman t...
Date May 1, 1987 Report No. 133014 Title

Special Publications: GS-13/14 Council 1986 Annual Report

3 Annual Report FOREWORD This the period three makeup addressed undertaken addition, the the through body The intensive 1984 GS-13/14 report summarizes and through (1) the Policy activities Advisory The 1986. section a section for Council, on the and accomplishments of into and Management January sections: of the in by the December a background (2) to is the on the Council for the report is divide...
Date Sept. 25, 1986 Report No. 131081 Title

Employment: Comments on Mandatory Drug Testing for Federal Employees

UNITED STATES GENERAL ACCOUNTING OFFICE Washington, D.C. 20548 FOR RELEASE ON DELIV3RY EXPECTED AT lo:30 A.M. SEPTEMBER 25, 1986 STATEMENT OF WILLIAM ASSISTANT J. ANDERSON COMPTROLLER GENERAL FOR GENERAL GOVERNMENT PROGRAMS AND HARRY R. VAN CLEVE GENERAL COUNSEL BEFORE THE STJBCOMMITTEE ON HUMAN RESOURCES COMMITTEE ON POST OFFICE AND CIVIL SERVICE HOUSE OF REPRESENTATIVES Mr. pleasure Executive em...
Date July 15, 1976 Report No. HRD-76-96 Title

Health: Federal Control of New Drug Testing Is Not Adequately Protecting Human Test Subjects and the Public

Food and Drug /M-ministration Department of Health, Education, and Welfare The Food and Drug Administration has neither adequately monitored new drug tests nor adequately enforced compliance with testing requirements. Consequently, it lacks assurance (1) that the thousands of human subjects used in such tests annually are protected from unnecessary hazards of new drugs or (2) that the test data us...